Cargando…
Progress in hepatectomy for hepatocellular carcinoma and peri-operation management
The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient manage...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452507/ https://www.ncbi.nlm.nih.gov/pubmed/32884986 http://dx.doi.org/10.1016/j.gendis.2020.02.001 |
_version_ | 1783575175441154048 |
---|---|
author | Chen, Hao Jia, Weidong |
author_facet | Chen, Hao Jia, Weidong |
author_sort | Chen, Hao |
collection | PubMed |
description | The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient management approaches, including enhanced recovery after surgery, targeted therapy, and immunotherapy. We compare traditional and innovative management methods, which comprise developments in precision medicine, and consider their limitations. Ongoing innovation and technological advances enable surgeons to gain deeper understandings of the multidimensionality of hepatocellular carcinoma, thereby promoting the continuous development of precision therapy. |
format | Online Article Text |
id | pubmed-7452507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Chongqing Medical University |
record_format | MEDLINE/PubMed |
spelling | pubmed-74525072020-09-02 Progress in hepatectomy for hepatocellular carcinoma and peri-operation management Chen, Hao Jia, Weidong Genes Dis Article The global incidence of liver cancer continues to grow. Liver cancer, especially hepatocellular carcinoma, has high recurrence and mortality rates. Here, we review the past decade's diagnostic, therapeutic, and management strategies for hepatocellular carcinoma, and summarize new patient management approaches, including enhanced recovery after surgery, targeted therapy, and immunotherapy. We compare traditional and innovative management methods, which comprise developments in precision medicine, and consider their limitations. Ongoing innovation and technological advances enable surgeons to gain deeper understandings of the multidimensionality of hepatocellular carcinoma, thereby promoting the continuous development of precision therapy. Chongqing Medical University 2020-03-28 /pmc/articles/PMC7452507/ /pubmed/32884986 http://dx.doi.org/10.1016/j.gendis.2020.02.001 Text en © 2020 Chongqing Medical University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Chen, Hao Jia, Weidong Progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
title | Progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
title_full | Progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
title_fullStr | Progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
title_full_unstemmed | Progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
title_short | Progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
title_sort | progress in hepatectomy for hepatocellular carcinoma and peri-operation management |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452507/ https://www.ncbi.nlm.nih.gov/pubmed/32884986 http://dx.doi.org/10.1016/j.gendis.2020.02.001 |
work_keys_str_mv | AT chenhao progressinhepatectomyforhepatocellularcarcinomaandperioperationmanagement AT jiaweidong progressinhepatectomyforhepatocellularcarcinomaandperioperationmanagement |